Alex Felix has won CURE Epilepsy’s Taking Flight Award to advance his work on “Fine-tuning the 3’UTR as a novel therapeutic strategy for genetic Developmental and Epileptic Encephalopathies.”
Charlene Son Rigby, President and Co-founder of the STXBP1 Foundation, interviews ENDD’s Mike Boland about STXBP1 therapeutic development updates from the annual meeting of the American Society for Gene and Cell Therapy.